A phase‐by‐phase review of migraine pathophysiology
DW Dodick - Headache: the journal of head and face pain, 2018 - Wiley Online Library
Migraine is a common, disabling neurological disorder characterized by multiple phases:
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …
Pathophysiology, prevention, and treatment of medication overuse headache
HC Diener, D Dodick, S Evers, D Holle… - The Lancet …, 2019 - thelancet.com
Regular or frequent use of analgesics and acute antimigraine drugs can increase the
frequency of headache, and induce the transition from episodic to chronic headache or …
frequency of headache, and induce the transition from episodic to chronic headache or …
Dual and opposing functions of the central amygdala in the modulation of pain
TD Wilson, S Valdivia, A Khan, HS Ahn, AP Adke… - Cell reports, 2019 - cell.com
Pain perception is essential for survival and can be amplified or suppressed by
expectations, experiences, and context. The neural mechanisms underlying bidirectional …
expectations, experiences, and context. The neural mechanisms underlying bidirectional …
Amygdala, neuropeptides, and chronic pain-related affective behaviors
Neuropeptides play important modulatory roles throughout the nervous system, functioning
as direct effectors or as interacting partners with other neuropeptide and neurotransmitter …
as direct effectors or as interacting partners with other neuropeptide and neurotransmitter …
Endogenous and exogenous opioids in pain
Opioids are the most commonly used and effective analgesic treatments for severe pain, but
they have recently come under scrutiny owing to epidemic levels of abuse and overdose …
they have recently come under scrutiny owing to epidemic levels of abuse and overdose …
Five decades of research on opioid peptides: current knowledge and unanswered questions
LD Fricker, EB Margolis, I Gomes, LA Devi - Molecular pharmacology, 2020 - ASPET
In the mid-1970s, an intense race to identify endogenous substances that activated the
same receptors as opiates resulted in the identification of the first endogenous opioid …
same receptors as opiates resulted in the identification of the first endogenous opioid …
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine
M Watanabe, CM Kopruszinski, A Moutal, D Ikegami… - Brain, 2022 - academic.oup.com
Migraine headache results from activation of meningeal nociceptors, however, the
hypothalamus is activated many hours before the emergence of pain. How hypothalamic …
hypothalamus is activated many hours before the emergence of pain. How hypothalamic …
Migraine treatment: Towards new pharmacological targets
M Silvestro, LF Iannone, I Orologio, A Tessitore… - International Journal of …, 2023 - mdpi.com
Migraine is a debilitating neurological condition affecting millions of people worldwide. Until
a few years ago, preventive migraine treatments were based on molecules with pleiotropic …
a few years ago, preventive migraine treatments were based on molecules with pleiotropic …
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache
E Navratilova, S Behravesh, J Oyarzo… - …, 2020 - journals.sagepub.com
Background Ubrogepant, a small-molecule calcitonin gene-related peptide receptor
antagonist, was recently approved as an oral medication for the acute treatment of migraine …
antagonist, was recently approved as an oral medication for the acute treatment of migraine …
Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain
Chronic pain is associated with neuroplastic changes in the amygdala that may promote
hyper-responsiveness to mechanical and thermal stimuli (allodynia and hyperalgesia) …
hyper-responsiveness to mechanical and thermal stimuli (allodynia and hyperalgesia) …